Bereskin & Parr LLP is a leading Canadian full service intellectual property law firm serving clients across all industries around the world. The firm services clients in every aspect of patent, trademark and copyright law, IP litigation and Regulatory, Advertising & Marketing.
Melanie Szweras and Teresa MacLean write for Biotechnology Focus Magazine discussing how gene patent elgibility in Canada may soon be evaluated in light of a challenge brought by the Children's Hospital of Eastern Ontario.
Melanie Szweras and Teresa MacLean write for Biotechnology
Focus Magazine discussing how gene patent elgibility in Canada
may soon be evaluated in light of a challenge brought by the
Children's Hospital of Eastern Ontario (CHEO).
To read the article please click here or download the PDF
below.
Originally published by Biotechnology Focus
Magazine.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
